Cited by 942Cytokine Signaling Pathways and InteractionsImmunodeficiency and Autoimmune DisordersNF-κB Signaling Pathways

The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.

JAKs and STATs in Immunity, Immunodeficiency, and Cancer

Open access

O'Shea, John J., Holland, Steven M., Staudt, Louis M.·2013·New England Journal of Medicine

DOI 10.1056/nejmra1202117PMC PMC7604876

Open this paper in CoChat — free account

Abstract

A large number of cytokines signal through the JAK–STAT pathway. Abnormal function of this pathway may lead to a variety of diseases. Targeting the defects in this signaling pathway has already led to treatment advances, and further advances are likely.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmra1202117

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
James, C., Ugo, V., Couedic, J. P. L., Staerk, J., Delhommeau, F., Lacout, C., Garçon, L., Raslová, H., Berger, R., Griscelli, A. B., et al. (2005) · Nature · doi:10.1038/nature03546 · Cited by 3,542
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J. P., Boggon, T. J., Wlodarska, I., Clark, J. J., Moore, S., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.023 · Cited by 2,993
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis
Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., Catalano, J. V., Deininger, M., Miller, C., Silver, R. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110557 · Cited by 2,103
JAKS AND STATS: Biological Implications
Leonard, W. J., & O’Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,826
Self-citation
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis
Harrison, C., Kiladjian, J.-J., Al-Ali, H. K., Gisslinger, H., Waltzman, R., Stalbovskaya, V., McQuitty, M., Hunter, D. S., Levy, R., Knoops, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110556 · Cited by 1,825
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Zhang, J., Ding, L., Holmfeldt, L., Wu, G., Heatley, S. L., Payne-Turner, D., Easton, J., Chen, X., Wang, J., Rusch, M., et al. (2012) · Nature · doi:10.1038/nature10725 · Cited by 1,596

Show all 101 references

Research works printed but not linked: 1

10.1172/JCI0215617 · DOI

Sorted by citations

Items 701–800 of 942

Eficacia y seguridad de baricitinib en pacientes con artritis reumatoide y respuesta inadecuada a FAME convencionales sintéticos o biológicos: datos de un registro local
Rosas, J., Gallego, J., Santos-Soler, G., Bernal, J. A., & Bas, A. P. (2020) · Reumatología Clínica · doi:10.1016/j.reuma.2020.04.011 · Cited by 3
A Systematic Review on the Erythropoietin Receptors Expression in Various Cancers and Importance of Recombinant Erythropoietin in Chemotherapy Induced Anaemia
Kumar, J. (2017) · Hematology & Transfusion International Journal · doi:10.15406/htij.2017.04.00072 · Cited by 3
Cytokines
O’Shea, J. J., Gadina, M., Siegel, R. M., & Farber, J. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00013-9 · Cited by 4
Self-citation
Transition of T Cells from Effector to Memory Phase
Schauder, D., & Cui, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.08013-9 · Cited by 3
Inborn Error of Immunity: A Journey Through Novel Genes and Clinical Presentation
Solimando, A. G., Vacca, A., & Ribatti, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00124-5 · Cited by 3
Cytokines in hematopoietic cell transplantation and related cellular therapies
Bazarbachi, A. H., & Mapara, M. Y. (2024) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2025.101600 · Cited by 2
Immune-related hub genes and their role in psoriasis pathogenesis
Yin, T., Zhang, T., & Ma, L. (2025) · Scientific Reports · doi:10.1038/s41598-025-02822-1 · Cited by 4
Analysis of the anti-fibrotic potential of a JAK inhibitor in a bleomycin-induced pulmonary fibrosis model
Nishimura, H., Kawano, H., Sato, S., Imakura, T., Yamashita, Y., Murakami, K., Haji, K., Bando, H., Naito, N., Kagawa, K., et al. (2025) · The Journal of Medical Investigation · doi:10.2152/jmi.72.298 · Cited by 2
Sex-specific transcriptome similarity networks elucidate comorbidity relationships
Sánchez-Valle, J., Flores-Rodero, M., Costa, F. X., Carbonell‐Caballero, J., Núñez‐Carpintero, I., Tabarés-Seisdedos, R., Rocha, L. M., Cirillo, D., & Valencia, A. (2025) · Communications Medicine · doi:10.1038/s43856-025-01329-0 · Cited by 2
Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
Burashed, K. K., & AlAbbasi, F. A. (2026) · Cureus · doi:10.7759/cureus.102634 · Cited by 2
From Coffee Alkaloid to Ovarian Targets: An Integrated Computational Framework for Trigonelline in Ovarian Aging
Yong, W. S., Han, Y., Shen, Y., Sun, N., & Zhang, Q. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71421 · Cited by 2
Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)
Wei, J., Cai, Q., Zhang, L., Zou, L., Li, Z., Zhou, K., Wu, H., Qiu, L., Su, L., Ding, K., et al. (2026) · Blood Cancer Journal · doi:10.1038/s41408-026-01452-8 · Cited by 2
Macrophage-associated kinase signaling in atherosclerosis – a systematic review
Müller, J. S., & van der Vorst, E. P. C. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02829-9 · Cited by 2
Single‐Cell Virtual Perturbation Screening Identifies STAT3 as a Key Regulator of Dentinogenesis
Zhu, Y., Xu, H., Zhang, Z., Sun, S., Huang, Z., Gao, X., Pan, H., Huang, X., Liu, Y., Wang, X., et al. (2026) · Cell Proliferation · doi:10.1111/cpr.70203 · Cited by 2
From CVID to PIRD: Genetic Testing Leading to Signal Transducer and Activator of Transcription 3 Gain-of-Function Diagnosis and Directed Therapy
Lang, A., Agharahimi, A., Vogel, T. P., Zhong, W., Cooper, M. A., Freeman, A. F., & Seroogy, C. M. (2026) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2026.03.041 · Cited by 2
Case Report: From Talaromyces marneffei infection to EBV-positive lymphoma in an adult with anti-IFN-γ autoantibody-associated immunodeficiency
Ning, Y., Huang, X., Liang, H., Liang, S., Qin, J., Chen, T., Shilian, L., Liang, X., Tan, F., Chen, N., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783319 · Cited by 2
Fundamentals of Physiology and Biology of Vascular System
Aoki, T., & Yamamoto, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-54801-0_3 · Cited by 2
Policitemia vera: presentación clínica, diagnóstico y nuevos abordajes terapéuticos.
Saavedra, M. A. C., & Mejía, C. R. (2018) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.18.2.2681.2018 · Cited by 2
Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis
Zhang, N., Zhang, C., Zeng, Z., Zhang, J., Du, S., Bao, C., & Wang, Z. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s301076 · Cited by 2
Integrated Bioinformatics Analysis for the Identification of Key lncRNAs, mRNAs, and Potential Drugs in Clear Cell Renal Cell Carcinomas
Liu, S., Shi, G., Pan, Z., Cheng, W., Xu, L., Lin, X., Lin, Y., Zhang, L., Ji, G., Lv, X., et al. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s409711 · Cited by 2
The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort
Yeh, T., Wang, H., Cho, S., Wu, C., Hsieh, T.-Y., Huang, C.-T., Wang, M., Chuang, B. T.-M., Gau, Y., Du, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11123113 · Cited by 2
A case report of systemic lupus erythematosus complicating interstitial lung disease and thickened pericardium treated with tofacitinib
Li, X., Luo, K., Yang, D., & Hou, C. (2024) · Medicine · doi:10.1097/md.0000000000039129 · Cited by 2
Efficacy and Safety of Upadacitinib for Axial Spondyloarthritis: A Systematic Review and Meta-Analysis
Ali, A. H. G., Elganady, A., Hindawi, M. D., Mousa, A. I. A., Eldeeb, H. A., Fatiem, A. R., & Skopina, Y. (2024) · Current Rheumatology Reviews · doi:10.2174/0115733971296457240805064237 · Cited by 2
Astrocytes in Glioblastoma Therapy: A Novel Approach to Targeting Tumor Microenvironment
Jayasinghe, R., & Danushka, P. G. N. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1008927 · Cited by 3
Efficacy of baricitinib in moderate alopecia areata, severe alopecia areata, alopecia totalis, and alopecia universalis: A real-world comparative study
Jiang, G., Liu, X., Jiang, X., & Zhang, Y. (2025) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2025.03.026 · Cited by 2
Colpomenia sinuosa extract mitigates lead acetate-induced testicular dysfunctions in male rats
Almutairi, L. A., Abu-Almakarem, A. S., Al‐Sowayan, N. S., Alkhodair, S. A., Albishi, H. M., Eid, T. M., Alshanbari, F. A., Abuzinadah, N. Y., Mobasher, M. A., & El-Said, K. S. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1551773 · Cited by 2
Understanding and Managing Hyper IgE Syndromes
Meric, Z., Aydin, M., Gumus, D. D., Yücel, E., & Kıykım, A. A. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s532287 · Cited by 2
Current and future pharmacotherapy for alopecia areata
Vázquez‐Herrera, N. E., & Tosti, A. (2015) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2015.1021778 · Cited by 2
Complex Primary Human Cell Systems for Drug Discovery
Berg, E. L., & O’Mahony, A. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782620136-00088 · Cited by 2
Cellular Inflammatory Responses
Land, W. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-78655-1_22 · Cited by 2
Development of a method for the determination of the JAK2 gene mRNA in venous blood and assessment of its diagnostic value in oncohematology
Stolyar, M. A., Горбенко, А. С., Olkhovskiy, I. A., Ивановна, Б. В., Mikhalev, M. A., Ольховик, Т. И., & Komarovskiy, Y. Y. (2021) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2021-66-6-379-384 · Cited by 2
Immunity/Immunopathology
Webb, K. C., Henning, S. W., & Poole, I. C. L. (2019) · Springer eBooks · doi:10.1007/978-3-319-62960-5_28 · Cited by 2
Efficacy and Safety of Baricitinib in Patients with Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic DMARDs and/or Biological DMARDs: Data from a Local Registry
Rosas, J., Gallego, J., Santos-Soler, G., Bernal, J. A., & Bas, A. P. (2020) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2020.04.008 · Cited by 2
The Role of the JAK/STAT Signalling Pathway in Immunoregulation of Gastrointestinal Cancers
Vaddi, K. (2017) · Springer eBooks · doi:10.1007/978-3-319-43063-8_7 · Cited by 2
Network based identification of different mechanisms underlying pathogenesis of human papilloma virus‐active and human papilloma virus‐negative oropharyngeal squamous cell carcinoma
Iman, M., Narimani, Z., Hamraz, I., & Ansari, E. (2018) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.201800072 · Cited by 2
First Reported Case of Pulmonary Arterial Hypertension Secondary to Tofacitinib Treatment for Undifferentiated Arthritis
Habib, P., Podgorski, M., Adorini, K., Brown, M. R., McLean, A., Tjeuw, M., Joshua, F., & Ng, B. (2018) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000889 · Cited by 2
STAT Immunodeficiency Disorders and Fungal Infection Susceptibility
Olbrich, P., & Ferreras-Antolin, L. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00413-x · Cited by 2
Study of Signal Transduction Pathways by Phospho-Protein Evaluation
Capone, M., Mazzoni, A., & Maggi, L. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1311-5_16 · Cited by 2
Overactive STAT3 drives accumulation of disease-associated CD21 low B cellsPreprint
Masle‐Farquhar, E., Peters, T. J., Jackson, K., Singh, M., Ma, C. S., Suan, D., Uzel, G., Chua, I. C., Leiding, J. W., Heiskanen, K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.20.473595 · Cited by 3
STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological dysregulation of NKG2D hi CD8 killer T cellsPreprint
Masle‐Farquhar, E., Jackson, K., Peters, T. J., Al‐Eryani, G., Singh, M., Payne, K. J., Rao, G., Apps, G., Kingham, J., Jara, C. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.11.480027 · Cited by 2
Myeloproliferative Neoplasms
Méndez‐Ferrer, S., & Fang, Z. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00237-6 · Cited by 2
STAT3 phosphorylation in the rheumatoid arthritis immunological synapsePreprint
Novak‐Kotzer, H., Capera, J., Jainarayanan, A., Mayya, V., Zanin‐Zhorov, A., Valvo, S., Macdonald, J., Taylor, P. C., & Dustin, M. L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.20.633875 · Cited by 2
Chronic Inflammation and Colorectal Cancer Microenvironment
廉, 文. (2015) · Advances in Clinical Medicine · doi:10.12677/acm.2015.54032 · Cited by 1
Serum Immunoglobulin Subclass Levels in Non-Hodgkin's Lymphoma in Ibadan, South Western Nigeria
Fasola, F. A., Olaniyi, J. A., Kotila, T. R., & Ogundeji, S. P. (2021) · Journal of Applied Hematology · doi:10.4103/joah.joah_205_20 · Cited by 1
Human Immunodeficiencies Caused by Inborn Errors of B-Cell Development or Function
Tangye, S. G., Casanova, J., & Ma, C. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95895-0.00013-1 · Cited by 1
Regulation and therapy: the role of ferroptosis in DLBCL
Wang, Y., He, Z., Dong, X., Yao, Y., Chen, Q., Shi, Y., Deng, Y., Zhang, Q., Yu, L., & Wang, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1458412 · Cited by 1
Identifying Novel JAK1 Inhibitors for Anti‐Rheumatoid Arthritis Through Structure‐Based Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulations
Banerjee, A., Bhuyan, P., & Guruprasad, L. (2025) · ChemistrySelect · doi:10.1002/slct.202500440 · Cited by 1
Human Cyclophilins—An Emerging Class of Drug Targets
Jurkova, K., Navrátilová, H., Musílek, K., & Benek, O. (2025) · Medicinal Research Reviews · doi:10.1002/med.70021 · Cited by 1
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral TYK2 Inhibitor D‐2570 in Healthy Subjects: A First‐in‐Human Phase I Study
Wang, M., Quan-ying, Z., Shi, Z., Zhang, L., & Pan, J. (2026) · Clinical and Translational Science · doi:10.1111/cts.70450 · Cited by 1
Advances in Janus Kinase Inhibitors for Vitiligo Treatment
Wang, W., Liao, Y., Zhang, R., Huang, J., Liu, J., Shan, X., Gao, X., Bu, J., Tang, Y., & Shen, E. (2026) · Drug Research · doi:10.1055/a-2784-6722 · Cited by 1
Lymphoproliferation in Inborn Errors of Immunity: Mechanisms, Manifestations and Clinical Management, with a Focus on ALPID
Gualtiero, G., Buso, H., Coopmans, E. C., Milito, C., Firinu, D., van Dalm, V., & Cinetto, F. (2026) · ImmunoTargets and Therapy · doi:10.2147/itt.s582718 · Cited by 1
Upadacitinib in rheumatoid arthritis: progress and challenges
Wang, Q., Zhong, L., Fu, Y., & Yang, Z. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1776317 · Cited by 1
Successful treatment of cutaneous small-vessel vasculitis with upadacitinib: a Case Report
Li, X., Wu, Z., Zhao, X., Liu, L., Li, H., Zhang, G., & Zhu, Q. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1804245 · Cited by 1
Rewiring osteoimmune homeostasis in osteoporosis: T-cell subsets as key regulators and emerging therapeutic targets
Gong, Y., Zeng, W., Liao, Y., Xie, X., Qin, Z., Li, C., & Zhang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1926935 · Cited by 1
Systems Immunology
Kidd, B. A., & Dudley, J. T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801577-3.00001-0 · Cited by 1
Changes and Recent Trends in Drug Therapy for Rheumatoid Arthritis
Maeda, M. (2020) · リハビリテーション医学 : 日本リハビリテーション医学会誌 · doi:10.2490/jjrmc.57.1011 · Cited by 1
Immunopathology and Immunotherapy of Hodgkin Lymphoma
Ebadi, M., Keshavarz‐Fathi, M., Zeng, Y., Gkotzamanidou, M. A., & Rezaei, N. (2020) · Springer eBooks · doi:10.1007/978-3-030-57949-4_6 · Cited by 1
Immunogenetic perspective of inflammatory disorders
Rai, G., Thacker, H., Das, D., & Priya, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90250-2.00009-1 · Cited by 1
Progress of IL-6/STAT3 Signaling Pathway in the Development and Treatment of Non-Small Cell Lung Cancer
唐, 玉. (2022) · Advances in Clinical Medicine · doi:10.12677/acm.2022.12111435 · Cited by 1
Treatment of the cytokine storm in COVID-19: review of clinical pharmacology
Sapriati, A. N., Rahmawati, F., & Nuryastuti, T. (2023) · Jurnal Sains Farmasi & Klinis · doi:10.25077/jsfk.10.2.162-183.2023 · Cited by 1
STAT1 Mutations in Chronic Mucocutaneous Candidiasis Diagnosed in an Adult
Andou, M., Tominaga, M., Nishikomori, R., Gotoh, K., Komatsu, N., Matsuoka, M., Kawayama, T., & Hoshino, T. (2023) · Internal Medicine · doi:10.2169/internalmedicine.2350-23 · Cited by 1
Tofacitinib for the treatment of severe rare skin diseases: a narrative review
Luo, F., Zhang, Y., & Wang, P. (2024) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-024-03621-9 · Cited by 1
Janus Kinases and Autoimmunity: Bridging Pathways to Therapy
Wei, Y., & Zhang, T. (2024) · International Journal of Drug Discovery and Pharmacology · doi:10.53941/ijddp.2024.100007 · Cited by 1
Tofacitinib in the treatment of ulceral colitis: real-world clinical practice and prospects
Трухан, Д. И. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-344 · Cited by 1
Review of the role of Janus kinase inhibitors in dermatology
Seyffert, J. L., & Kramer, O. N. (2017) · Journal of the Egyptian Womenʼs Dermatologic Society · doi:10.1097/01.ewx.0000508179.74890.d3 · Cited by 1
New Emerging Molecules in Cancer Research Which Hold Promise in Current Era
Bhatia, D. R., Rath, S., & Gupta, S. (2019) · Springer eBooks · doi:10.1007/978-981-32-9816-3_20 · Cited by 1
The role of targeted synthetic drugs in the treatment of rheumatic diseases: focus on tofacitinib
Karateev, D. E., & Лучихина, Е. Л. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-2-83-94 · Cited by 1
Development of piperidinyl dipyrrrolopyridine-based dual inhibitors of Janus kinase and Bruton’s tyrosine kinase: a potential therapeutic probability to deal with rheumatoid arthritis
Pery, N., Rizvi, N. B., & Shafiq, M. I. (2020) · Journal of Molecular Modeling · doi:10.1007/s00894-020-04512-3 · Cited by 2
Role of Perforin-2 in Regulating Type I Interferon Signaling
Plano, G. V., & Shembade, N. (2021) · Journal of Cellular Immunology · doi:10.33696/immunology.3.078 · Cited by 1
Granulomatous disease and the two faces of Janus: divergent effects of tofacitinib therapy for inflammatory arthritis
Yee, A. M. F. (2022) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/2hu4yl · Cited by 1
Forward Genetics in Apicomplexa Biology: The Host Side of the Story
Sánchez‐Arcila, J. C., & Jensen, K. D. C. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.878475 · Cited by 1
The role of interleukin-6 and janus kinases in the pathogenesis, and treatment of SARS-CoV-2
Syabbalo, N. (2022) · Journal of Lung Pulmonary & Respiratory Research · doi:10.15406/jlprr.2022.09.00273 · Cited by 2
Back to the future: oral small molecule kinases
Fleischmann, R. (2013) · Lara D. Veeken · doi:10.1093/rheumatology/ket155 · Cited by 1
Receptors for the Four‐Helical Cytokines
Rose‐John, S. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0000930.pub3 · Cited by 1
The Study on the Regulation of Th Cells by Mesenchymal Stem Cells Through the JAK-STAT Signaling Pathway to Protect Naturally Aged Sepsis RatsPreprint
Wang, L., Deng, Z., Sun, Y., Zhao, Y., Li, Y., Yang, M., Yuan, R. R., Liu, Y., Qian, Z., Zhou, F., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3961380 · Cited by 1
Modulation of the JAK2/STAT3 pathway in vivo : understanding reactive astrocyte functional features and contribution to neurodegenerative diseases
Haim, L. B. (2014) · theses.fr (ABES) · doi:10.70675/75a69111z994cz43dfzb795zfeae9ffc88ab · Cited by 1
Investigating the role of the PGF2alpha/calcineurin-signaling pathway in the regulation of adipogenesis
Annamalai, D. (2014) · Loyola eCommons (Loyola University of Chicago)
Caractérisation moléculaire des carcinomes hépatocellulaires liés au virus de l'hépatite B
Cao, Q. (2014) · theses.fr (ABES) · doi:10.70675/b0c5123czd7d0z43abz9475z2af650db1f39
Inhibition von Signalkaskaden in der immunsuppressiven Therapie nach Nierentransplantation
Tebbe, B., & Wilde, B. (2014) · Der Nephrologe · doi:10.1007/s11560-014-0918-5
MicroRNA-155 mediates sepsis-associated cardiovascular dysfunction
Carreiras, F. B. (2015) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/1vmm-d187
Hypoxia‐inducible factor and signal transducer and activators of transcription 3: two central regulators meet to regulate kidney pathophysiology
Nakayama, K., & Nangaku, M. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12071
Development of ruxolitinib as a myelofibrosis therapy
Verstovšek, S., Aleem, A., Al-Momen, A., & Newberry, K. J. (2013) · Journal of Applied Hematology · doi:10.4103/1658-5127.123299
Immunopathology and Immunotherapy of Hodgkin Lymphoma
Ebadi, M., Zeng, Y., Gkotzamanidou, M. A., & Rezaei, N. (2015) · Springer eBooks · doi:10.1007/978-3-662-46410-6_7
ROLE OF STAT3 IN HUMAN NK CELL FUNCTIONS
Phatarpekar, P. V. (2015) · Digital Commons-TMC (Texas Medical Center)
Perú y Brasil : hacia una asociación binacional
González-Vigil, F. (1994) · Agenda Internacional · doi:10.18800/agenda.199402.005
Immunity and Disease Mechanisms of Jak/STAT Signaling in
O’Shea, J. J., Villarino, A. V., Kanno, Y., & Ferdinand, J. R. (2015)
Self-citation
Estudo da mutação da STAT5B em Criciúma-Santa Catarina: frequência e caracterização fenotípica de indivíduos heterozigotos
Scalco, R. C. (2015) · doi:10.11606/t.5.2015.tde-24112015-101444
Principles of Signaling
Moulton, V. R., Suárez‐Fueyo, A., Bradley, S., & Tsokos, G. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00027-9
STATs in Health and Disease
Liongue, C., Lewis, R. S., & Ward, A. C. (2016) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-42949-6_1
Estudo da mutação da STAT5B em Criciúma - Santa Catarina: frequência e caracterização fenotípica de indivíduos heterozigotos
Jorge, L. (2015)
JAK inhibitors as therapy for myelofibrosis
Verstovšek, S., & Newberry, K. J. (2015) · doi:10.2217/fmeb2014.14.14
Abnormalities in the psoriatic non-lesional skin
Gubán, B. (2016) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2974
Inhibition Of Inflammatory Signaling Via The Il-6-Stat3 Pathway And Its Effects On Growth And Survival Of Triple Negative Breast Cancer Cells
Chubbs, N. (2016) · Library, Museums and Press - UDSpace (University of Delaware)
Design and Synthesis of Small Molecule Agonists Targeting Type I Interferon and Vitamin D Receptors
Keca, J. M. (2014) · TSpace (University of Toronto)
The role of fusion oncogenes and cancer stem cells in myxoid liposarcoma
Dolatabadi, S. (2017) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Endocrine Metabolism I
Bhagavan, N. V., & Ha, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-416687-5.00028-2
Januskinaseinhibitoren
Aringer, M., & Karonitsch, T. (2017) · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen · doi:10.1007/s41970-017-0001-6
Inhalational Delivery of a JAK3 Inhibitor for the Novel Treatment of Asthma and the Investigation of Pharmaceutical Salts in HFA Propellant Systems
Younis, U. S. (2018) · UA Campus Repository (The University of Arizona)
Janus Kinases (JAKs)/STAT Pathway
Afzali, B., & John, S. (2014) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_36-1
Inibição farmacológica dos substratos do receptor de insulina em neoplasia mieloproliferativa JAK2V617F
Fenerich, B. A. (2018) · doi:10.11606/d.17.2018.tde-02042018-111147

Authors: O'Shea, J. J., Holland, S. M., & Staudt, L. M.
Affiliations: National Institute of Allergy and Infectious Diseases (US)
National Institutes of Health (US)
ORCID: Holland, Steven M.
Staudt, Louis M.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2013-01-10
Volume: 368
Issue: 2
Pages: 161-170
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra1202117
PMC: PMC7604876
OpenAlex: W2040002852
Cited by: 927
References: 101
Citations by year: 2026: 47 · 2025: 61 · 2024: 64 · 2023: 76 · 2022: 79 · 2021: 91 · 2020: 78 · 2019: 60 · 2018: 44 · 2017: 70 · 2016: 66 · 2015: 69 · 2014: 67 · 2013: 52
FWCI: 8.98
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health
National Cancer Institute (Z01SC004024)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (ZIAAR041106)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: JAK/STAT signaling, cytokine signaling, immunodeficiency, cancer, immune regulation, JAK inhibitors, STAT inhibitors, targeted therapy
MeSH terms: Hematologic Diseases, Humans, Immunologic Deficiency Syndromes, Mutation, Neoplasms, Signal Transduction, Cytokines, STAT Transcription Factors, Janus Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

JAKs and STATs in Immunity, Immunodeficiency, and Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks